Who makes Corticoid Acetonide triamcinolone 0.2%?

Corticoid Acetonide triamcinolone 0.2% is developed by Pia Lopez Jornet.

What development phase is Corticoid Acetonide triamcinolone 0.2% in?

Corticoid Acetonide triamcinolone 0.2% is in Phase 1.

Last reviewed 2026-05-15 · How we verify

Corticoid Acetonide triamcinolone 0.2%

Pia Lopez Jornet · Phase 1 active Small molecule

At a glance

Generic name	Corticoid Acetonide triamcinolone 0.2%
Also known as	GropupII
Sponsor	Pia Lopez Jornet
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Corticoid Acetonide triamcinolone 0.2% CI brief — competitive landscape report
Corticoid Acetonide triamcinolone 0.2% updates RSS · CI watch RSS
Pia Lopez Jornet portfolio CI